Fri, Jul 25, 2014, 5:02 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

IntelliCell BioSciences, Inc. Message Board

  • lchris12345 lchris12345 Nov 8, 2013 9:08 AM Flag

    Possible New Treatment for Permanent Bell’s Palsy

    Interesting update on SVFC potential. Can't put the link here so Google it - saw the article this morning.

    Babak Azizzadeh, MD, FACS, Director of the Facial Paralysis Institute, comments on the recent treatment of a Bell’s palsy patient with stromal vascular fraction cells.

    Beverly Hills, CA (PRWEB) November 08, 2013

    An article published October 9, 2013, on CNN described the recent treatment of a patient living with permanent Bell’s palsy and Type I diabetes with IntelliCell Biosciences, Inc.’s stromal vascular fraction cells. Stromal vascular fraction cells (SVFC) are developed from adult autologous vascular cells derived from blood vessels. Babak Azizzadeh, MD, FACS, renowned Bell’s palsy and facial paralysis surgeon, says this patient’s experience may bring hope to others with permanent Bell’s palsy.
    ....

    The patient who was treated with the SVFC had undergone many unsuccessful treatments in the past, and was eventually given the new stem cell applications. He received two treatments 6 months apart. The patient experienced complete Bell’s palsy recovery and--as an unintended benefit—improvement of his diabetes condition. IntelliCell Biosciences is hopeful that its product will be revolutionary for the treatment of medical conditions that don't respond to traditional therapy, particularly Bell’s palsy.

    Sentiment: Hold

 
SVFC
0.0016+0.0001(+6.67%)Jul 25 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.